• Author Archives: ino_admin

    Inositec featured in BioCentury

    BioCentury is featuring Inositec in this week’s emerging company profile. Read the article here (requires subscription).

    Posted in News | Leave a comment

    Interview of Inositec CEO by Scrip Intelligence

    Scrip Intelligence interviewed Mattias Ivarsson at BIO Europe 2016 in Cologne. The video can be found here.

    Posted in News | Leave a comment

    Inositec AG Secures CHF1.4 million in Seed Financing to Advance New Class of Inositol Hexaphosphate-Based Drug Candidates

    Lead programs address unmet medical needs in vascular calcification and C. difficile infection Zurich, Switzerland, 27th October 2016 – Inositec, a pioneer in the development of life-saving small molecule drugs based on inositol hexaphosphate (IP6), announced today the closing of a … Continue reading

    Posted in Press Release | Leave a comment

    Inositec nominated for the 2016 deVigier prize

    Inositec has been short-listed together with 10 nominees for the deVigier prize. More info here. 29th March 2016

    Posted in News | Leave a comment

    Inositec CEO named on Forbes 30 under 30 list

    Mattias Ivarsson appeared in the Science and Healthcare category of the 2016 Forbes 30 under 30 European list. 1st March 2016

    Posted in News | Leave a comment

    Inositec CEO featured in ETH Globe magazine

    Mattias Ivarsson has a vision: he wants to keep a dangerous pathogen in check using an innovative approach. As a Pioneer Fellow, he is now taking his first steps on the path to making that vision a reality. Click here for … Continue reading

    Posted in News | Leave a comment

    Inositec wins Winterthur Heuberger Young Entrepreneur Award

    Three Zurich-based start-ups were awarded this year’s Heuberger Winterthur Start-up Award. The three companies from the Life Sciences field each received CHF 150,000 in prize money. Three other start-ups were awarded CHF 50,000 each. Click here for an article and … Continue reading

    Posted in News | Leave a comment

    Inositec ranked 3rd in Switzerland’s premier business plan competition

    Check out the newsflash, the >>venture>> website or our video for more information. 18th June 2015

    Posted in News | Leave a comment

    An innovative fight against the bacterium Clostridium difficile

    Mattias Ivarsson is committed to fighting a nasty bacterium at the root of many hospital-acquired infections. This article describes the story behind Inositec’s technology and CEO. 10th November 2014

    Posted in News | Leave a comment

    Du nouveau contre le Clostridium difficile

    Swiss national radio interviews Mattias Ivarsson about Inositec’s therapeutic approach to treat Clostridium difficile infection (in French). Audio link 6th November 2014

    Posted in News | Leave a comment